Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

NAOV

NanoVibronix Inc

Apr 18 • 04:00PM ET

0.7500

Dollar change 0.0000
Percentage change 0.00	%

Healthcare • Medical Devices • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-2.13	Insider Own	0.38%	Shs Outstand	2.78M	Perf Week	-5.06%
Market Cap	2.08M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	2.77M	Perf Month	-18.48%
Income	-3.71M	PEG	-	EPS next Q	-	Inst Own	3.85%	Short Float	0.10%	Perf Quarter	-8.54%
Sales	2.28M	P/S	0.91	EPS this Y	-	Inst Trans	26.93%	Short Ratio	0.03	Perf Half Y	-33.04%
Book/sh	1.95	P/B	0.38	EPS next Y	-	ROA	-	Short Interest	0.00M	Perf Year	-78.39%
Cash/sh	1.18	P/C	0.64	EPS next 5Y	-	ROE	-	52W Range	0.70 - 4.34	Perf YTD	-34.78%
Dividend Est.	-	P/FCF	-	EPS past 5Y	30.29%	ROI	-93.05%	52W High	-82.72%	Beta	1.30
Dividend TTM	-	Quick Ratio	1.53	Sales past 5Y	80.85%	Gross Margin	67.32%	52W Low	7.14%	ATR (14)	0.07
Dividend Ex-Date	-	Current Ratio	2.64	EPS Y/Y TTM	49.14%	Oper. Margin	-150.42%	RSI (14)	35.23	Volatility	6.91% 8.58%
Employees	16	Debt/Eq	0.00	Sales Y/Y TTM	-	Profit Margin	-162.55%	Recom	1.00	Target Price	10.50
Option/Short	No / Yes	LT Debt/Eq	0.00	EPS Q/Q	41.76%	Payout	-	Rel Volume	0.04	Prev Close	0.75
Sales Surprise	-23.48%	EPS Surprise	40.00%	Sales Q/Q	1113.40%	Earnings	-	Avg Volume	99.12K	Price	0.75
SMA20	-12.24%	SMA50	-21.54%	SMA200	-51.96%	Trades		Volume	3,476	Change	0.00%

Apr-10-24 07:52AM	NAOV Stock Earnings: NanoVibronix Reported Results for Q4 2023 (InvestorPlace) -9.15%
Apr-09-24 08:30AM	NanoVibronix Issues Letter to Stockholders (Business Wire)
Mar-28-24 08:30AM	NanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShield (Business Wire)
Dec-06-23 09:00AM	NanoVibronix Featured in Your Bladder Health Magazine (Business Wire)
Dec-04-23 09:00AM	NanoVibronix Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution Opportunity (Business Wire)
09:00AM	Loading…
Nov-28-23 09:00AM	NanoVibronix Announces Agreement for Clinical Study of UroShield at the University of Michigan (Business Wire) -13.87%
Nov-21-23 08:30AM	NanoVibronix Regains Nasdaq Compliance (Business Wire) +9.16%
Nov-14-23 08:30AM	NanoVibronix Issues Letter to Shareholders (Business Wire)
Nov-07-23 08:30AM	NanoVibronix UroShield Products Available on NHS Drug Tariff Effective November 1 (Business Wire)
Sep-27-23 08:00AM	NanoVibronix Gains Approval for Inclusion of UroShield Products in NHS Prescription Services Drug Tariff (Business Wire)
Sep-06-23 08:30AM	NanoVibronix Announces Presentation of Positive Independent Testing Results of UroShield at ICS Annual Meeting (Business Wire) -8.48%
Aug-30-23 02:29PM	NanoVibronix Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules (Business Wire) +67.59%
12:07PM	Why Is NanoVibronix Stock Trading Higher Today? (Benzinga)
08:30AM	NanoVibronix Cites Positive Results from Independent Testing of UroShield (Business Wire)
Aug-29-23 04:05PM	NanoVibronix Responds to CMS Determination for PainShield (Business Wire)
08:30AM	Loading…
Aug-28-23 08:30AM	NanoVibronix Applies for Inclusion of UroShield Products in NHS Prescription Services Drug Tariff (Business Wire) -14.04%
Aug-23-23 08:45AM	NanoVibronix Extends Distribution Agreement with Its Largest Distributor for PainShield and PainShield Plus (Business Wire) -5.62%
Jun-14-23 08:30AM	NanoVibronix Announces Distribution Agreement with Sports Medicine Supplier Mio-Guard (Business Wire)
May-18-23 08:30AM	NanoVibronix Issues Letter to Shareholders (Business Wire)
Apr-18-23 08:30AM	NanoVibronix Issues Letter to Shareholders (Business Wire)
Mar-28-23 08:30AM	NanoVibronix Receives Positive Final Results of Independent Lifecycle Testing of PainShield Prompted by Centers for Medicare and Medicaid Services (CMS) (Business Wire)
Mar-21-23 08:30AM	NanoVibronix Files Provisional U.S. Patent Application for UroShield Ultra (Business Wire) +8.29%
Mar-14-23 09:15AM	NanoVibronix Announces Positive Results from Independent Product Trial of UroShield for Patients with a Spinal Cord Injury (Business Wire)
Mar-03-23 08:30AM	NanoVibronix Regains Nasdaq Compliance (Business Wire)
Feb-22-23 08:30AM	NanoVibronix to Launch Rental Program for PainShield and UroShield (Business Wire) +5.08%
Feb-08-23 12:00PM	NanoVibronix Announces Reverse Stock Split (Business Wire) -15.38%
Jan-18-23 08:30AM	NanoVibronix Provides Update on Expanding Access to PainShield (Business Wire) -7.57%
Dec-15-22 04:05PM	NanoVibronix Announces Results of Annual Meeting of Stockholders Held Today (Business Wire)
Dec-13-22 08:30AM	NanoVibronix Announces Partnership with Peak Medical, Ltd. (Business Wire)
Dec-09-22 06:11AM	Shareholders Will Likely Find NanoVibronix, Inc.'s (NASDAQ:NAOV) CEO Compensation Acceptable (Simply Wall St.)
02:06PM	Loading…
Dec-01-22 02:06PM	NanoVibronix Announces Closing of $2.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (Business Wire)
Nov-29-22 08:07AM	NanoVibronix Announces $2.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (Business Wire) -21.00%
Nov-28-22 03:18PM	NanoVibronix Receives FDA 510(k) Premarket Clearance for PainShield Plus (Business Wire) +144.27%
Nov-17-22 06:23AM	NanoVibronix Third Quarter 2022 Earnings: US$0.034 loss per share (vs US$0.26 loss in 3Q 2021) (Simply Wall St.)
Nov-16-22 10:15AM	Interim Results Of NanoVibronix's Uroshield Show Beneficial Effects For Patients (Benzinga)
08:30AM	NanoVibronix Announces Interim Results of Clinical Study for UroShield (Business Wire)
Nov-15-22 08:33AM	NanoVibronix Provides Business Update in Letter to Shareholders (Business Wire)
Oct-19-22 08:30AM	NanoVibronix Receives Extension to Satisfy Nasdaq Price Requirement (Business Wire)
Sep-23-22 08:30AM	NanoVibronix UroShield Approved for Sale through NHS Internal Supply Chain Contract (Business Wire) +25.17%
Sep-14-22 04:05PM	NanoVibronix Sets Date for Annual Shareholder Meeting (Business Wire)
09:25AM	NanoVibronix Announces Distribution of Series F Preferred Stock to Holders of its Common Stock (Business Wire)
Sep-02-22 04:30PM	NanoVibronix Announces Receipt of Nasdaq Listing Determination; Company to Request Hearing (Business Wire)
Aug-18-22 11:30AM	NanoVibronix Provides Business Update in Letter to Shareholders (Business Wire)
Jul-25-22 08:30AM	Will NanoVibronix (NASDAQ:NAOV) Spend Its Cash Wisely? (Simply Wall St.) -5.15%
Jul-12-22 08:30AM	NanoVibronix Announces Webinar Series to Promote UroShield (Business Wire)
Jun-29-22 08:30AM	NanoVibronix Strengthening Supply Chain Increasing Efficiency and Scalability (Business Wire)
May-17-22 08:30AM	NanoVibronix Reports First Quarter 2022 Financial Results (Business Wire) +5.16%
May-04-22 08:30AM	NanoVibronix Announces FDA 510(k) Submission for PainShield® MD PLUS (Business Wire) +5.39%
Apr-25-22 08:30AM	NanoVibronix Adds Additional Product to Federal Supply Schedule (Business Wire) +7.40%
Apr-05-22 08:30AM	NanoVibronix Advances Efforts to Achieve NHS Approval (Business Wire) -7.63%
Mar-30-22 11:16AM	Health Canada Approves NanoVibronix's PainGuard, UroGuard As Licensed Devices (Benzinga) +22.64%
08:30AM	NanoVibronix Announces PainGuard and UroGuard Approved by Health Canada as Licensed Medical Devices (Business Wire)
Feb-14-22 01:45PM	Is NanoVibronix (NASDAQ:NAOV) In A Good Position To Deliver On Growth Plans? (Simply Wall St.) -5.86%
Feb-07-22 08:30AM	NanoVibronix Added an Additional National Payer Network in Workers Compensation Market (Business Wire)
Jan-31-22 04:15PM	AM Best Upgrades Ratings of CNO Financial Group to A (Excellent) (PR Newswire)
Jan-24-22 08:30AM	NanoVibronix Extends Reach of UroShield and PainShield through MTSGs International Network (Business Wire)
Jan-19-22 08:30AM	NanoVibronix Files Three U.S. Patent Applications Further Leveraging Its Innovative Surface Acoustic Wave Technology (Business Wire)
Jan-13-22 08:30AM	NanoVibronix Expands Board of Directors with Appointment of Two New Independent Directors (Business Wire)
Jan-07-22 01:02PM	NanoVibronix to Present at the H.C. Wainwright BioConnect Virtual Conference (Business Wire)
Jan-06-22 08:30AM	NanoVibronix Further Expands VA Distribution Network to Include SDVOSB Delta Medical, LLC (Business Wire)
Jan-05-22 08:30AM	NanoVibronix Selects Key Distributor to Exclusively Distribute PainShield for Veterans Administration Facilities (Business Wire) -7.27%
Dec-21-21 03:15PM	NanoVibronix, Medina Ink Distribution Pact For Ultrasound Devices In Europe (Benzinga)
10:30AM	NanoVibronix Adjourns Special Meeting of Stockholders (GlobeNewswire)
08:00AM	NanoVibronix Announces Agreement With Medina Healthcare Limited for Distribution of UroShield® and PainShield® in European Market Expansion (Business Wire)
Dec-15-21 09:01AM	11 Best One Dollar Stocks to Buy Today (Insider Monkey) +6.93%
Dec-08-21 11:10AM	CNO Financial Group Selects 2021 Holiday and New Year's Card Winner (PR Newswire)
08:30AM	NANOVIBRONIX TO SHOWCASE PAINSHIELD PRODUCTS AT 75TH ANNUAL WORKERS COMPENSATION EDUCATIONAL CONFERENCE DECEMBER 12-15 (GlobeNewswire)
Dec-07-21 09:00AM	CNO Financial Group Names Richard Shaffer Senior Vice President (PR Newswire)
08:30AM	NanoVibronix Announces Encouraging Interim Results in Real World Patient Study of UroShield (GlobeNewswire)
Dec-02-21 05:30AM	NanoVibronix Announces Early Success in the Marketing of Painshield to Veterans Administration Healthcare Providers (GlobeNewswire)
Nov-16-21 08:30AM	NanoVibronix Reports Third Quarter 2021 Financial Results (Business Wire) -9.72%
Oct-28-21 09:28AM	NanoVibronix CEO Brian Murphy Provides Business Update in Letter to Shareholders (GlobeNewswire)
Oct-11-21 10:40AM	NanoVibronix Shares Gain As PainShield Shows Effectiveness In Treating Soft Tissue Pain (Benzinga) +17.65%
09:06AM	NANOVIBRONIX ANNOUNCES POSITIVE RESULTS FROM INDEPENENT, DOUBLE-BLIND TRIAL OF PAINSHIELD (GlobeNewswire)
Sep-29-21 10:14AM	NANOVIBRONIX ENTERS WORKERS COMPENSATION MARKET THROUGH AGREEMENT WITH ORCHID MEDICAL (GlobeNewswire) +7.03%
Sep-14-21 12:12PM	NanoVibronix Launches CBD-Based Product For Pain Management (Benzinga) -9.46%
08:30AM	NANOVIBRONIX EXTENDS LINE-UP OF PAIN MANAGEMENT PRODUCTS (GlobeNewswire)
Aug-17-21 02:32PM	NanoVibronix Announces Results of Annual Meeting of Stockholders Held Today (Business Wire) -12.76%
10:26AM	We're Hopeful That NanoVibronix (NASDAQ:NAOV) Will Use Its Cash Wisely (Simply Wall St.)
07:02AM	25 Stocks Moving in Tuesday's Pre-Market Session (Benzinga)
Aug-16-21 04:05PM	NanoVibronix Reports Second Quarter 2021 Financial Results; Provides Business Update (GlobeNewswire) +33.73%
12:13PM	Mid-Day Market Update: Crude Oil Down Over 2%; Travere Therapeutics Shares Jump (Benzinga)
10:22AM	Mid-Morning Market Update: Markets Open Lower; Empire State Manufacturing Index Dips In August (Benzinga)
08:30AM	NANOVIBRONIX ANNOUNCES PLAN TO EXPAND PRODUCT PORTFOLIO WITH INTRODUCTION OF PAINSHIELD RELIEF FOR OVER-THE-COUNTER (OTC) USE AND PLANS FOR FUTURE PRODUCT LAUNCH (GlobeNewswire)
Aug-11-21 08:30AM	NANOVIBRONIX RECEIVES REGISTRATION APPROVAL FOR PAINSHIELD FROM TGA AUSTRALIA (GlobeNewswire)
Aug-05-21 08:52AM	NanoVibronix Applies for CMS Reimbursement Code for UroShield® and PainShield Plus® (Business Wire) +20.10%
Jul-29-21 09:00AM	NanoVibronix Receives Registration Approval for UroShield From TGA Australia (Business Wire) +26.18%
Jul-26-21 10:47AM	NanoVibronix Ships First Order of PainShield Plus (Business Wire) -27.20%
04:44AM	Premarket Movers Monday: NanoVibronix, Alibaba, Lumen, Hasbro (TheStreet.com)
04:36AM	NanoVibronix Jumps on Positive UTI Medical Device Reception (TheStreet.com)
Jul-23-21 03:03PM	NanoVibronix stock triples in very active trading after upbeat report on UTI treatment (MarketWatch) +248.14%
Jul-22-21 08:15AM	NanoVibronix Announces Publication of Compelling Study Results for UroShield in The Journal of Medical & Surgical Urology (GlobeNewswire) -6.23%
Jun-03-21 08:30AM	NanoVibronix Provides Business Update (GlobeNewswire) +15.63%
Apr-27-21 11:17AM	NanoVibronix Adjourns Special Meeting of Stockholders (GlobeNewswire)
Apr-26-21 09:00AM	NanoVibronix Announces Expanded CMS Reimbursement Approval for PainShield (GlobeNewswire) +14.69%
Apr-19-21 09:50AM	NanoVibronix Announces Start of Real World Patient Study of UroShield (Business Wire)
Apr-14-21 12:57PM	NanoVibronix Adjourns Special Meeting of Stockholders (GlobeNewswire) +6.01%
Mar-31-21 06:50PM	NanoVibronix Adjourns Special Meeting of Stockholders (Business Wire)
Mar-02-21 08:30AM	NanoVibronix UroShield Joins PainShield on Federal Supply Schedule, Expanding Access to VA Market (Business Wire)
Feb-10-21 08:00AM	NanoVibronix Reports Schedule Published by NICE for Review of UroShield® Device (Business Wire)

NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. The firm's products include UroShield and PainShield. It operates through the following geographical segments: United States, Europe, Australia, India, Israel, and Other. The company was founded by Harold Jacob and Jona Zumeris in September 2003 and is headquartered in Elmsford, NY.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NAOV

NanoVibronix Inc

Upgrade your FINVIZ experience